Literature DB >> 26432789

Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome.

Bing Shu1,2, Qi Shi3,4, Yong-jun Wang5,6.   

Abstract

Primary osteoporosis (POP) is one of the most common diseases in the elderly people resulting in high risk of fracture and poor quality of life. In addition to the pathological changes in bone mass, most of the POP patients also suffer from Chinese medicine (CM) syndromes of Shen (Kidney) essence deficiency. Shen essences are highly related to bone. Shen essence deficiency plays an important part in the development of POP and a better diagnosis of POP could be made by combining CM syndromes with Western medicine risk factors. Treatments of POP should aim at both increasing the bone mass and relieving the syndromes of Shen essence deficiency. Clinical study confirmed that treating POP patients with Shen-tonifying herbs could increase the bone mass and relieve the CM syndromes of POP patients. Basic researches clarified the mechanism by which Shen-tonifying herbs increased bone mass in animal models. The mechanisms by which Shentonifying herbs relieve the CM syndromes are still in investigation.

Entities:  

Keywords:  Chinese medicine; Shen (Kidney) essence deficiency; Shen (Kidney)-tonifying herbs; primary osteoporosis; syndrome

Mesh:

Substances:

Year:  2015        PMID: 26432789     DOI: 10.1007/s11655-015-2306-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  34 in total

1.  [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro].

Authors:  Lei-Guo Ming; Ming-Gang Wang; Ke-Ming Chen; Jian Zhou; Gui-Qiu Han; Rui-Qing Zhu
Journal:  Yao Xue Xue Bao       Date:  2012-02

2.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

3.  Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.

Authors:  Yu Zhao; Yue Huai; Jie Jin; Mei Geng; Jian-Xin Li
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

Review 4.  Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.

Authors:  Maurizio Rossini; Davide Gatti; Silvano Adami
Journal:  Calcif Tissue Int       Date:  2013-06-11       Impact factor: 4.333

5.  Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.

Authors:  Toshiaki Ishii; Hidefumi Furuoka; Yoshikage Muroi; Masakazu Nishimura
Journal:  J Biol Chem       Date:  2003-04-24       Impact factor: 5.157

6.  Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.

Authors:  Jun-Feng Li; Yu Zhao; Min-Min Cai; Xiao-Fei Li; Jian-Xin Li
Journal:  Eur J Med Chem       Date:  2008-12-31       Impact factor: 6.514

7.  Prevention and management of osteoporosis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2003

8.  Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation.

Authors:  Martina Rauner; Wolfgang Sipos; Peter Pietschmann
Journal:  Age (Dordr)       Date:  2008-09-02

9.  Different molecular targets of Icariin on bMSCs in CORT and OVX -rats.

Authors:  Qin Bian; Jian-hua Huang; Shu-fen Liu; You Ning; Zhu Yang; Yong-jian Zhao; Zi-yin Shen; Yong-jun Wang
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

Review 10.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

View more
  10 in total

1.  An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis.

Authors:  Fulong Gu; Jiang Jiang; Sheng Wang; Tao Feng; Yi Zhou; Yong Ma; Shuijie Shen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study.

Authors:  W-J Chen; H Livneh; M-H Hsieh; C-C Yeh; M-H Yeh; M-C Lu; J-T Chien; T-Y Tsai
Journal:  Osteoporos Int       Date:  2019-02-05       Impact factor: 4.507

3.  Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.

Authors:  Bo-Cheng Liang; Xiao-Lin Shi; Chun-Wen Li; Zhen-Yu Shi; Wei-Tao He; Jian-Liang Yao; Ling-Cheng Kong; Xu-Yun Li
Journal:  Chin J Integr Med       Date:  2016-07-07       Impact factor: 1.978

4.  The Efficacy and Safety of Traditional Chinese Medicine Tonifying-Shen (Kidney) Principle for Primary Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Junquan Liang; Fengyi Wang; Jiajia Huang; Yunxiang Xu; Guizhen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-06       Impact factor: 2.629

5.  Effectiveness and safety of traditional Chinese medicine in the treatment of steroid-osteonecrosis of femoral head: A protocol for systematic review and meta-analysis.

Authors:  Peilin He; Junming Chen; Chen Yue; Maoxiao Ma; Zhenqiang Hong; Youwen Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

Review 6.  Effects of Chinese herbal formula Erxian decoction for treating osteoporosis: a systematic review.

Authors:  Jin-Yu Li; Yu-Song Jia; Li-Min Chai; Xiao-Hong Mu; Sheng Ma; Lin Xu; Xu Wei
Journal:  Clin Interv Aging       Date:  2017-01-04       Impact factor: 4.458

Review 7.  Mechanisms of Zuogui Pill in Treating Osteoporosis: Perspective from Bone Marrow Mesenchymal Stem Cells.

Authors:  Aofei Yang; Chaochao Yu; Fang You; Chengjian He; Zhanghua Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-19       Impact factor: 2.629

8.  Effects of Acupoint Application Therapy with TianGui Powder on Osteoporosis in Ovariectomized Rats through TGF-β1 and Smad2/3 Signaling Pathway.

Authors:  Xiao-Sheng Lin; Hai-Yan Wang; Zhen Zhang; Han-Jiao Liu; Zhen Qu; Ke-Liang Wu; Qing-Hua Xiao; Jian-Zong Zhu; Ping Zhang
Journal:  Orthop Surg       Date:  2019-02       Impact factor: 2.071

9.  Development of software enabling Chinese medicine-based precision treatment for osteoporosis at the gene and pathway levels.

Authors:  Jinyu Li; Guiyu Feng; Haoyang He; Haolin Wang; Jia Tang; Aiqing Han; Xiaohong Mu; Weifeng Zhu
Journal:  Chin Med       Date:  2022-04-15       Impact factor: 4.546

10.  Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the "kidney governing bone" theory.

Authors:  Baojin Yao; Jia Liu; Mei Zhang; Xiangyang Leng; Daqing Zhao
Journal:  J Orthop Surg Res       Date:  2020-04-15       Impact factor: 2.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.